Literature DB >> 24990954

Thematic minireview series on phospholipase D and cancer.

Julian Gomez-Cambronero1, George M Carman2.   

Abstract

Phospholipase D (PLD) signaling plays a critical role in cell growth and proliferation, vesicular trafficking, secretion, and endocytosis. At the cellular level, PLD and its reaction product, phosphatidate, interact with a large number of protein partners that are directly related to the actin cytoskeleton and cell migration. Cancer invasion and metastasis rely heavily on cellular motility, and as such, they have put PLD at center stage in cancer research. This minireview series highlights some of the molecular mechanisms that provide evidence for the emerging tumorigenic potential of PLD, the role of the microenvironment, and putative connections with inflammation. PLD represents a potential target for the rational development of therapeutics against cancer and other diseases.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cancer; Inflammation; Lipid Signaling; Phosphatidate; Phospholipase D

Mesh:

Substances:

Year:  2014        PMID: 24990954      PMCID: PMC4132762          DOI: 10.1074/jbc.R114.593137

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  A new phospholipide-splitting enzyme specific for the ester linkage between the nitrogenous base and the phosphoric acid grouping.

Authors:  D J HANAHAN; I L CHAIKOFF
Journal:  J Biol Chem       Date:  1947-08       Impact factor: 5.157

2.  Dual role for phosphoinositides in regulation of yeast and mammalian phospholipase D enzymes.

Authors:  Vicki A Sciorra; Simon A Rudge; Jiyao Wang; Stuart McLaughlin; JoAnne Engebrecht; Andrew J Morris
Journal:  J Cell Biol       Date:  2002-12-16       Impact factor: 10.539

Review 3.  Regulation of mTOR by phosphatidic acid?

Authors:  David A Foster
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

Review 4.  Signaling functions of phosphatidic acid.

Authors:  Xuemin Wang; Shivakumar Pattada Devaiah; Wenhua Zhang; Ruth Welti
Journal:  Prog Lipid Res       Date:  2006-03-15       Impact factor: 16.195

5.  Increased activity and intranuclear expression of phospholipase D2 in human renal cancer.

Authors:  Y Zhao; H Ehara; Y Akao; M Shamoto; Y Nakagawa; Y Banno; T Deguchi; N Ohishi; K Yagi; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  2000-11-11       Impact factor: 3.575

6.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.

Authors:  Robert Lavieri; Sarah A Scott; Jana A Lewis; Paige E Selvy; Michelle D Armstrong; H Alex Brown; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2009-03-06       Impact factor: 2.823

7.  Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells.

Authors:  Stewart M Knoepp; Manpreet S Chahal; Yuhuan Xie; Zhihong Zhang; Daniel J Brauner; Mark A Hallman; Stephanie A Robinson; Shujie Han; Masaki Imai; Stephen Tomlinson; Kathryn E Meier
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

8.  Expression of phospholipase D2 in human colorectal carcinoma.

Authors:  Masaru Saito; Manabu Iwadate; Masashi Higashimoto; Koichiro Ono; Yuji Takebayashi; Seiichi Takenoshita
Journal:  Oncol Rep       Date:  2007-11       Impact factor: 3.906

9.  Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.

Authors:  Sarah A Scott; Paige E Selvy; Jason R Buck; Hyekyung P Cho; Tracy L Criswell; Ashley L Thomas; Michelle D Armstrong; Carlos L Arteaga; Craig W Lindsley; H Alex Brown
Journal:  Nat Chem Biol       Date:  2009-01-11       Impact factor: 15.040

10.  5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.

Authors:  Wenjuan Su; Oladapo Yeku; Srinivas Olepu; Alyssa Genna; Jae-Sook Park; Hongmei Ren; Guangwei Du; Michael H Gelb; Andrew J Morris; Michael A Frohman
Journal:  Mol Pharmacol       Date:  2008-12-08       Impact factor: 4.436

View more
  3 in total

1.  Anti-Metastatic Effect of Gold Nanoparticle-Conjugated Maclura tricuspidata Extract on Human Hepatocellular Carcinoma Cells.

Authors:  Sun Young Park; Beomjin Kim; Zhengwei Cui; Geuntae Park; Young-Whan Choi
Journal:  Int J Nanomedicine       Date:  2020-07-27

2.  Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.

Authors:  Mehrdad Pazhouhandeh; Fatemeh Samiee; Tahereh Boniadi; Abbas Fadaei Khedmat; Ensieh Vahedi; Mahsa Mirdamadi; Naseh Sigari; Seyed Davar Siadat; Farzam Vaziri; Abolfazl Fateh; Faezeh Ajorloo; Elham Tafsiri; Mostafa Ghanei; Fereidoun Mahboudi; Fatemeh Rahimi Jamnani
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

Review 3.  The Significant Role of the Microfilament System in Tumors.

Authors:  Xin Jiang; Yiming Qin; Liu Kun; Yanhong Zhou
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.